Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer

被引：1
|
作者：
Sousa, Catarina C. [1 ]
Pinto, Josue [1 ]
Martins, Natalia [1 ,2 ,3 ]
Teixeira, Sofia [4 ]
Magalhaes, Adriana [1 ]
Fernandes, Gabriela [1 ,2 ,3 ]
Hespanhol, Venceslau [1 ,2 ,3 ]
Queiroga, Henrique [1 ,2 ,3 ]
Bastos, Helder Novais [1 ,2 ,3 ]
机构：
[1] Univ Hosp Ctr Sao Joao, Dept Pulmonol, Porto, Portugal
[2] Univ Porto, Fac Med, Porto, Portugal
[3] Univ Porto, Inst Res & Innovat Hlth, Porto, Portugal
[4] Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.PA4684
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4684
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
    Nygaard, Anneli Dowler
    Spindler, Karen-Lise Garm
    Pallisgaard, Niels
    Andersen, Rikke Fredslund
    Jakobsen, Anders
    LUNG CANCER, 2013, 79 (03) : 312 - 317
  • [22] One year survival differences of EGFR- and KRAS-mutated advanced non-small cell lung cancer (NSCLC) compared to the wildtype population
    Boch, Christian
    Kollmeier, Jens
    Roth, Andreas
    Misch, Daniel
    Streubel, Anna
    Mairinger, Thomas
    Bauer, Torsten T.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [23] Brain metastases in clinical trial participants with KRAS-mutated advanced non-small cell lung cancer receiving docetaxel: Pooled data analysis
    Aptekar, Jacob
    Jain, Rahul
    Korytowsky, Beata
    Shafquat, Afrah
    Hendershot, Jacob
    Talwai, Aniketh
    Itzkovich, Yahav
    Padda, Sukhmani K.
    LUNG CANCER, 2024, 193
  • [24] Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation
    Barsouk, Adam
    Friedes, Cole
    Iocolano, Michelle
    Doucette, Abigail
    Cohen, Roger B.
    Robinson, Kyle W.
    D'Avella, Christopher A.
    Marmarelis, Melina E.
    Kosteva, John A.
    Singh, Aditi P.
    Ciunci, Christine A.
    Levin, William P.
    Cengel, Keith A.
    Bradley, Jeffrey D.
    Feigenberg, Steven J.
    Sun, Lova
    Aggarwal, Charu
    Langer, Corey J.
    Yegya-Raman, Nikhil
    CLINICAL LUNG CANCER, 2024, 25 (03) : e161 - e171
  • [25] Tumor-immune microenvironment analysis of de novo and acquired KRAS-mutated non-small cell lung cancer
    Reuss, J.
    Gandhi, N.
    Walker, P.
    Nieva, J.
    Alvarez, J. G. Bustamante
    Carlisle, J.
    Desai, A.
    Van der Walde, A. M.
    Ma, P. C.
    Liu, S. V.
    ANNALS OF ONCOLOGY, 2023, 34
  • [26] Prognostic Factors for Patients With KRAS Mutated Non-Small Cell Lung Cancer and Brain Metastases
    Tsakonas, G.
    Skribek, M.
    Kamali, C.
    Zerdes, I.
    Johannsdottir, B.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S599 - S599
  • [27] Neoadjuvant Chemotherapy or Chemo-IO in Resectable KRAS-Mutated Non-small Cell Lung Cancer (NSCLC) Patients: Single Center Experience
    Wang, K.
    Alvarez, F. R. Rojas
    Leung, C. H.
    Kemp, H.
    Lewis, W. E.
    Arrechedera, C. A.
    Soto, L. M. Solis
    Blumenschein, G.
    Sepesi, B.
    Skoulidis, F.
    Heymach, J. V.
    Gibbons, D. L.
    Zhang, J.
    Wistuba, I. I.
    Lee, J. J.
    Weissferdt, A.
    Swisher, S. G.
    Pataer, A.
    Cascone, T.
    Negrao, M. V.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S558 - S559
  • [28] Clinical Impact of Next-Generation Sequencing in KRAS-Mutated Non-Small Cell Lung Cancer Patients: a Single-Center Experience
    Anagnostakis, M.
    Panagiotou, E.
    Karachaliou, A.
    Kolintzikis, V.
    Tsamis, I.
    Vathiotis, I. A.
    Syrigos, N. K.
    Nikolaidou, V.
    Papafili, A.
    Kotteas, E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S485 - S485
  • [29] Combined inhibition of MEK and p38 efficiently inhibits cell growth of KRAS-mutated non-small cell lung cancer
    Sunaga, Noriaki
    Miura, Yosuke
    Tsukagoshi, Yusuke
    Kasahara, Norimitsu
    Sakurai, Reiko
    Kaira, Kyoichi
    Hisada, Takeshi
    CANCER SCIENCE, 2018, 109 : 587 - 587
  • [30] Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer
    Sunaga, Noriaki
    Miura, Yosuke
    Tsukagoshi, Yusuke
    Kasahara, Norimitsu
    Masuda, Tomomi
    Sakurai, Reiko
    Kaira, Kyoichi
    Hisada, Takeshi
    ONCOLOGY LETTERS, 2019, 17 (03) : 3569 - 3575
12345